Vecna Technologies, a developer of patient self-service systems, has integrated its onsite patient check-in platform with Imprivata's PatientSecure identification technology. Through the partnership, hospitals and ambulatory practices will be able to use Imprivata's biometric palm vein scanning technology to securely ID patients who are checking in using Vecna's platform.
from MobiHealthNews https://ift.tt/2LeRtWL
May 18, 2018
Rose
MobiHealthNews
No comments
Related Posts:
Fitbit invests $6M in glucose monitoring startup SanoFitbit has recently invested $6 million in San Fransisco-based Sano, a company developing a mobile app and sensor that will allow users to continuously monitor blood glucose levels, multiple publications have confirmed. … Read More
Healthcare cost, quality transparency company Amino launches its own HSA, debit cardSan Francisco-based Amino, which has offered a consumer-facing cost and quality transparency tool since 2015, is launching a new offering: its own Health Savings Account (HSA) and debit card. from MobiHealthNews http://ift.t… Read More
University of Iowa Children's Hospital puts patient experience firstPatient engagement is important and the healthcare experience – particularly in inpatient settings – is increasingly seen by providers as a critically valuable priority. from MobiHealthNews http://ift.tt/2Eq5UDa … Read More
Glucose monitor maker Intuity Medical brings in $40MFremont, California-based Intuity Medical, a diabetes management technology company, announced that it will be receiving $40 million in equity financing from several of its previous investors, including Accuitive Medical Vent… Read More
HIMSS18 Patient Engagement and Experience Summit: New strategies for precision medicine, telehealth, social determinantsLots of health systems pay lip service to patient-centric care, but what does that really mean? As healthcare continues its transition to paying for value and outcomes, toward managing wellness rather than treating disease, m… Read More
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment